Wednesday, November 24, 2021 5:02:36 PM
You can go to this link to check short interest in a stock:
http://nasdaqtrader.com/Trader.aspx?id=ShortInterest
Publication schedule is here:
http://nasdaqtrader.com/Trader.aspx?id=ShortIntPubSch
Settlement Date Short Interest Percent Change
Average Daily Share Volume Days to Cover
11/15/2021 177,107 2124.40 808,889 1.00
10/29/2021 7,962 (83.75) 1,857,416 1.00
10/15/2021 49,012 233.69 352,134 1.00
09/30/2021 14,688 (25.95) 119,242 1.00
09/15/2021 19,834 26.07 16,674 1.19
08/31/2021 15,733 (11.53) 18,667 1.00
08/13/2021 17,784 (52.59) 26,087 1.00
07/30/2021 37,510 (51.73) 21,437 1.75
07/15/2021 77,706 904.34 59,460 1.31
06/30/2021 7,737 (32.19) 29,894 1.00
06/15/2021 11,409 (64.02) 8,295 1.38
05/28/2021 31,708 270.85 7,999 3.96
05/14/2021 8,550 (16.24) 27,827 1.00
04/30/2021 10,208 11.62 89,060 1.00
04/15/2021 9,145 495.77 6,454 1.42
03/31/2021 1,535 148.78 65,155 1.00
03/15/2021 617 (99.39) 52,716 1.00
02/26/2021 101,294 12853.20 100,564 1.01
02/12/2021 782 22,705 1.00
Recent SABS News
- SAB Biotherapeutics Provides SAB-142 Trial Update • GlobeNewswire Inc. • 04/16/2024 11:15:00 AM
- SAB Biotherapeutics to Present at INNODIA Annual Meeting • GlobeNewswire Inc. • 04/08/2024 11:15:00 AM
- SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/04/2024 11:15:00 AM
- SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results • GlobeNewswire Inc. • 03/29/2024 11:15:00 AM
- SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment • GlobeNewswire Inc. • 03/25/2024 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:55:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:45:19 PM
- SAB Biotherapeutics to Present at the BIO CEO & Investor Conference • GlobeNewswire Inc. • 02/23/2024 01:00:00 PM
- SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/08/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 12:53:44 PM
- SAB Biotherapeutics Announces Executive Leadership Change • GlobeNewswire Inc. • 02/02/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 09:15:19 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/26/2024 09:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 10:00:09 PM
- SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 01/23/2024 10:58:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:21:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 02:00:08 PM
- SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split • GlobeNewswire Inc. • 01/02/2024 09:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/18/2023 02:34:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/08/2023 10:26:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 10:00:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 12:40:46 PM
- SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 Diabetes • GlobeNewswire Inc. • 11/29/2023 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/29/2023 05:15:09 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM